Anticoagulant Therapy in Initially Low‐Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors

Anticoagulant Therapy in Initially Low‐Risk Patients With Nonvalvular Atrial Fibrillation Who Develop Risk Factors

Background The CHA2DS2‐VASc score has been validated for stroke risk prediction in patients with atrial fibrillation (AF). Antithrombotic therapy is not recommended for low‐risk patients with AF (CHA2DS2‐VASc 0 [male] or 1 [female]). We studied a cohort of initially low‐risk patients with AF in rela...

Full description

Bibliographic Details
Main Authors: Sun Young Choi, Moo Hyun Kim, Kwang Min Lee, Young‐Rak Cho, Jong Sung Park, Seong Woo Kim, Jin Kyung Kim, Matthew Chung, Sung‐Cheol Yun, Gregory Y. H. Lip
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anticoagulant
atrial fibrillation
death
intracranial hemorrhage
stroke
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.016271

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.016271

Similar Items